Virus potentiation of tumor vaccine T-cell stimulatory capacity requires cell surface binding but not infection.

Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo

1996 • 1,077 citations

T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds

1996 • 1,038 citations

The human CD46 molecule is a receptor for measles virus (Edmonston strain)

1993 • 1,024 citations

Cell adhesion. Competition between nonspecific repulsion and specific bonding

1984 • 680 citations

Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus

1976 • 651 citations

Reproduction of Paramyxoviruses

1975 • 247 citations

Newcastle disease virus selectively kills human tumor cells

1992 • 235 citations

Newcastle disease virus as an antineoplastic agent

1965 • 214 citations

Treatment of human cancer with mumps virus

1974 • 207 citations

Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation.

1983 • 148 citations

Newcastle Disease Virus as an Antineoplastic Agent: Induction of Tumor Necrosis Factor- and Augmentation of Its Cytotoxicity2

1988 • 143 citations

Complete Regression of Human Neuroblastoma Xenografts in Athymic Mice After Local Newcastle Disease Virus Therapy

1994 • 122 citations

New Developments in the Virus Therapy of Cancer: A Historical Review

1993 • 115 citations

A ten-year follow-up on stage II Malignant Melanoma patients treated postsurgically with newcastle disease virus oncolysate

1992 • 113 citations

Attenuated veterinary virus vaccine for the treatment of cancer.

1993 • 111 citations

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. I. Parameters for optimal therapeutic effects

1986 • 109 citations

Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer.

1997 • 103 citations

Molecular Cloning of Complementary DNA to Newcastle Disease Virus, and Nucleotide Sequence Analysis of the Junction between the Genes Encoding the Haemagglutinin-Neuraminidase and the Large Protein

1986 • 98 citations

Tumour Immunity induced in Mice with Cell-free Homogenates of Influenza Virus-infected Tumour Cells

1971 • 94 citations

Modification of tumor cells by a low dose of Newcastle disease virus

1990 • 88 citations

Intracellular processing of the Newcastle disease virus fusion glycoprotein

1985 • 77 citations

Viral Xenogenization of Intact Tumor Cells

1979 • 71 citations

Monoclonal antibodies as functional probes of the HN glycoprotein of Newcastle disease virus: antigenic separation of the hemagglutinating and neuraminidase sites.

1984 • 68 citations

Viruses as immunological adjuvants in cancer

1974 • 68 citations

Viral hemagglutinin augments peptide‐specific cytotoxic T cell responses

1993 • 62 citations

Tumor metastases and cell‐mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti‐tumor immunity in vivo and of cytolytic T cells in vitro

1979 • 58 citations

Monoclonal antibodies to hemagglutinin-neuraminidase and fusion glycoproteins of Newcastle disease virus: relationship between glycosylation and reactivity

1986 • 58 citations

In vitro and clinical characterisation of a newcastle disease virus-modified autologous tumour cell vaccine for treatment of colorectal cancer patients

1991 • 58 citations

Induction of NO synthesis in macrophages by Newcastle disease virus is associated with activation of nuclear factor-κB

1996 • 52 citations

Modification of tumor cells by a low dose of Newcastle Disease Virus.

1988 • 51 citations

Mechanism of virus-induced stimulation of the hypothalamus-pituitary-adrenal axis

1989 • 47 citations

Effective anti‐metastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with newcastle disease virus (NDV)

1994 • 42 citations

999 Newcastle disease virus infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma

1995 • 42 citations

Characterization of the anti-tumor immune response in human cancers and strategies for immunotherapy

1994 • 38 citations

Viral Oncolysates as Human Tumor Vaccines

1991 • 38 citations

TUMOR RESPONSE AND 4 YEAR SURVIVAL-DATA OF PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA TREATED WITH AUTOLOGOUS TUMOR VACCINE AND SUBCUTANEOUS R-IL-2 AND IFN-ALPHA(2B)

1995 • 37 citations

Immunotherapy of advanced gynecologic cancer patients utilizing mumps virus.

1988 • 35 citations

EFFECTIVE IMMUNE REJECTION OF ADVANCED METASTASIZED CANCER

1995 • 34 citations

Differential Expression of Interferon Alpha and Beta Induced with Newcastle Disease Virus in Mouse Macrophage Cultures

1989 • 33 citations

Isolation of a human melanoma adapted Newcastle disease virus mutant with highly selective replication patterns.

1990 • 32 citations

Active Specific Immunotherapy of Established Micrometastasis: Effect of Cryopreservation Procedures on Tumor Cell Immunogenicity in Guinea Pigs23

1980 • 32 citations

Tumour‐Specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens

1993 • 31 citations

Successful immunotherapy of the highly metastatic murine ESb lymphoma with sensitized CD8⁺ T cells and IFN‐α/β

1994 • 26 citations

Oncolytic Potentials of Nonhuman Viruses for Human Cancer. I. Effects of Twenty-Four Viruses on Human Cancer Cell Lines<xref ref-type="fn" rid="FN2">2</xref>

1963 • 23 citations

Increased or decreased immunogenicity of tumor-associated antigen according to the amount of virus-associated antigen in rat tumor cells infected with friend virus

1982 • 22 citations

Generation of a lymphocyte growth factor by treatment of human cells with neuraminidase and galactose oxidase.

1980 • 22 citations

The restrictive role of sialic acid in antigen presentation to a subset of human peripheral cd4⁺ t lymphocytes that requires antigen‐presenting dendritic cells

1989 • 20 citations

Biological consequences of neuraminidase deficiency in Newcastle disease virus

1983 • 19 citations

The lectin neuraminidase inhibition test: a new method for the detection of antibodies to neuraminidase

1983 • 19 citations

Comparison of the positions and efficiency of cleavage activation of fusion protein precursors of virulent and avirulent strains of newcastle disease virus: Insights into the specificities of activating proteases

1990 • 17 citations

Protection of mice against cancer by immunization with membranes but not purified virions from virus infected cancer cells

1975 • 14 citations

ADHESIVE FUNCTION OF NEWCASTLE-DISEASE VIRUS HEMAGGLUTININ IN TUMOR-HOST INTERACTION

1995 • 12 citations

Feasibility of UV-inactivated vaccinia virus in the modification of tumor cells for augmentation of their immunogenicity

1986 • 8 citations

Tumor therapy of neoplastic diseases with tumor cells and neuraminidase: Experimental studies on chessboard vaccination in transplantation tumors

1987 • 3 citations